Aspergillus fischeri is a very close evolutionary relative of the major cause of invasive 23 mold infections, Aspergillus fumigatus. In contrast to A. fumigatus, A. fischeri rarely causes 24 invasive disease, but why such a discrepancy between the species exists is unknown. To begin to 25 address this question, we characterized the pathogenic, genomic, and secondary metabolic 26 similarities and differences between A. fischeri and A. fumigatus. We observed multiple 27 differences between the two species for phenotypes related to pathogenesis, including that A. 28 fischeri is less virulent than A. fumigatus in multiple murine models of invasive disease. In 29 contrast, ~90% of the A. fumigatus proteome is conserved in A. fischeri, including all but one of 30 the previously known A. fumigatus genetic determinants important for virulence. However, the 31 two species differed substantially in their biosynthetic gene clusters (BGCs) that are likely 32 involved in the production of secondary metabolites, with only 10 / 33 A. fumigatus BGCs also 33 conserved in A. fischeri. Detailed chemical characterization of A. fischeri cultures grown on 34 multiple substrates identified multiple secondary metabolites, including two new compounds and 35 one never before isolated as a natural product. Interestingly, a deletion mutant in A. fischeri of 36 the ortholog of a master regulator of secondary metabolism, laeA, produced fewer secondary 37 metabolites and in lower quantities, suggesting that regulation of secondary metabolism is at 38 least partially conserved between the two species. These results suggest that the less-pathogenic 39
tests). Mice inoculated with A. fumigatus all succumbed to infection by day 3; however, similar 134 to the neutropenic model, animals inoculated with A. fischeri had a slower disease progression 135 ( Fig. 1C ). We observed similar results when using the Galleria mellonella insect larvae model of 136 aspergillosis infection (Fig. 1EF ). Both low (1x10 6 conidia) and high (1x10 9 conidia) inoculum 137 experiments showed significant differences between the disease progression of A. fischeri and A. 138
fumigatus. 139 140
To better understand what is happening in vivo during infection with A. fischeri and A. 141 fumigatus, we performed histological analysis on lungs from the triamcinolone model 3 days 142 post inoculation. Histological sections were stained with Gomori methenamine silver (GMS) to 143 visualize fungal growth and hematoxylin and eosin (H&E) stain to visualize host cell infiltration 144 ( Fig. 1D ). Overall, mice inoculated with A. fischeri had similar numbers of fungal lesions to 145 those inoculated with A. fumigatus but the lesions caused by the two species were phenotypically 146 8 distinct. In large airways infected with A. fumigatus, there was greater fungal growth per lesion, 147 and the growth was observed throughout the major airway itself. These lesions are accompanied 148 by inflammation, which appears largely neutrophilic and obstructs the airways surrounding the 149 hyphae. In the lesions containing A. fischeri, the fungal growth is contained to the epithelial 150 lining of the airways. This pattern of growth is accompanied by inflammation at the airway 151 epithelia, leaving the large airways largely unobstructed. The lack of airway obstruction during 152
A. fischeri infection may contribute to the reduced virulence compared to A. fumigatus. 153
154
Although the distribution of the fungal lesions varies, there is still significant fungal 155 growth in these animals, suggesting that A. fischeri is capable of growing within the host. Indeed, 156
we tested the growth rate of A. fischeri and A. fumigatus in lung homogenate as a proxy for 157 growth capability within the nutrient environment of the host and observed no difference 158 between the two strains ( Fig. S1) . These experiments show that in two murine models of IPA, A. 159 fischeri is less virulent than A. fumigatus, although A. fischeri is still capable of causing disease 160 using a higher dose and importantly, is able to grow within the murine host. 161 162 A. fischeri is more susceptible to several infection-relevant stresses than A. fumigatus 163
Our in vivo experiments suggested that the attenuation of virulence is not solely a result 164 of the inability of A. fischeri to grow within the host, therefore we hypothesized that the inability 165 to mitigate host stress is a contributing factor to the virulence defects. Nutrient fluctuation is a 166 stress encountered in vivo during A. fumigatus infection (31). To assess differences in metabolic 167 plasticity between the two strains, growth was measured on media supplemented with glucose, 168 fatty acids (Tween-80), or casamino acids. Because low oxygen tension is a significant stress 169 9 encountered during infection (5), and recently, fitness in low oxygen has been correlated to 170 virulence of A. fumigatus (32), we measured growth of both strains at 37°C in both normoxic 171 (ambient air) and hypoxia-inducing (0.2% O 2 , 5% CO 2 ) conditions. In normoxia with glucose, 172 fatty acids (Tween-80), or casamino acids supplied as the carbon source, radial growth of A. 173 fischeri was lower than that of A. fumigatus. However, on rich media both strains grew equally 174 well (Fig. 2) . We also observed a slower growth rate of A. fischeri compared to A. fumigatus in 175 the first 16 hours of culture in liquid media supplied with glucose at 37°C. At 30°C A. fischeri 176 grew the same as, or better than, A. fumigatus except on Tween-80 where A. fumigatus has a 177 slight advantage ( Fig. S2 ). Also, A. fischeri grew substantially worse than A. fumigatus when 178 grown at 44°C (Fig. S3 ). To determine relative fitness in hypoxic liquid environments, we 179 measured the ratio of biomass in liquid culture in ambient air (normoxia) versus hypoxic (0.2% 180 O 2 , 5%CO 2 ) conditions. A. fischeri showed significantly lower fitness in hypoxia, with about an 181 8.5-fold lower biomass than A. fumigatus (Fig. 3A) . These data suggest that A. fischeri is less fit 182 than A. fumigatus at 37°C and in low oxygen conditions, both of which have been shown to 183 impact fungal virulence. 184 185 Metabolic flexibility, or the ability for an organism to utilize multiple carbon sources 186 simultaneously, has been suggested to provide a fitness advantage to Candida albicans during in 187 vivo growth (33). Metabolic flexibility can be characterized using the glucose analog, 2-188 deoxyglucose (2-DG), in combination with an alternative carbon source available in vivo such as 189 lactate. 2-DG triggers carbon catabolite repression, which shuts down alternative carbon 190 utilization pathways. However, in C. albicans this shut down is delayed and growth occurs on 191 lactate with 2-DG (33, 34). We tested this phenomenon in both A. fumigatus and A. fischeri and 192 10 observed that while both strains can grow in the presence of 2-DG on lactate, growth of A. 193 fischeri is more inhibited under these conditions (~60%) compared to A. fumigatus (~35%; Fig.  194 3B). Even under low oxygen conditions (5% and 2%), A. fumigatus maintains this metabolic 195 flexibility except under extremely low oxygen conditions (0.2%), whereas A. fischeri is even 196 more inhibited at all oxygen tensions of 5% or below. Thus, these data suggest that while both 197 species exhibit some level of metabolic flexibility, A. fumigatus appears more metabolically 198 flexible under a wider range of conditions than A. fischeri. 199
200
Next, we measured the susceptibility of A. fischeri to oxidative stress, cell wall stress, and 201 antifungal drugs. Interestingly, we observed that A. fischeri is more resistant to the intracellular 202 generating oxidative stress agent menadione than A. fumigatus and is more susceptible to 203 external oxidative stress agent H 2 O 2 than A. fumigatus (Fig. 3CD ). As levels of inflammation 204 appeared different between the species in vivo, we indirectly tested for differences in cell wall 205 pathogen associated molecular patterns using cell wall perturbing agents Congo Red and 206
Calcofluor White. For both of these agents, A. fumigatus was significantly more resistant than A. 207 fischeri suggesting differences in the response to cell wall stress or in the composition and 208 organization of the cell wall ( Fig. 3C ). This is especially important for host immune cell 209 recognition and interaction and will influence pathology and disease outcome. Lastly, A. fischeri 210 showed enhanced resistance relative to A. fumigatus for three of the four antifungal drugs tested 211 (Table 1) , similar to what has been shown in the past (35). Overall, our phenotypic data show 212 variability in the response of A. fischeri to host-related stresses and antifungals. Increased growth 213 capability in low oxygen and thermotolerance are two important attributes that likely contribute 214 to the success of A. fumigatus as a pathogen compared to A. fischeri. 215 12 cluster genes present in A. fumigatus and A. fischeri. Using the program antiSMASH (39) we 239 identified 598 secondary metabolic cluster genes distributed amongst 33 clusters in A. fumigatus 240 strain CEA10 (Table S2 ) and 786 secondary metabolite cluster genes spread out over 48 clusters 241 in A. fischeri strain NRRL 181 (Table S3 ). Of the 598 secondary metabolic cluster genes we 242 identified in A. fumigatus, 407 of them had an ortholog that was also in an A. fischeri secondary 243 metabolic gene cluster. This level of conservation between secondary metabolic cluster genes 244 (68%) is much lower than the amount of conservation seen when considering proteins from the 245 entire genome (88%), illustrating the rapid rate at which these metabolic pathways and genomic 246 architectures can change and evolve. 247
248
We next sought to directly compare the list of A. fischeri secondary metabolic gene 249 clusters to the list of secondary metabolic gene clusters from A. fumigatus. An A. fumigatus gene 250 cluster was considered conserved in A. fischeri if 90% or more of its genes were also in an A. 251 fischeri gene cluster. Only 10 out of the 33 A. fumigatus gene clusters are conserved in A. 252 fischeri ( Fig. 4) , confirming our individual gene-based findings that secondary metabolism in A. 253 fumigatus and A. fischeri is quite different. 254 255 While only 10 A. fumigatus gene clusters were conserved in A. fischeri, many others 256 possessed at least one ortholog that could be found in an A. fischeri secondary metabolic gene 257 cluster. However, one gene cluster (Cluster 18) was completely A. fumigatus-specific (i.e. it did 258 not have any orthologs in the A. fischeri secondary metabolic gene clusters or in the rest of the A. 259 fischeri genome), and antiSMASH predicted this gene cluster to produce a terpene-based 260 metabolite. Our search for A. fumigatus virulence factors in A. fischeri revealed that pesL, the 261 13 NRPS from the fumigaclavine biosynthetic pathway, was not present in A. fischeri, and our 262 expanded gene cluster search showed that only one gene from the entire fumigaclavine gene 263 cluster is present in A. fischeri, again suggesting that fumigaclavine production is likely not 264 present in A. fischeri. In addition, there are 10 A. fischeri gene clusters that do not have any 265 orthologs in secondary metabolic gene clusters in A. fumigatus. One of these A. fischeri-specific 266 gene clusters is responsible for making helvolic acid (a gene cluster known to be absent from the 267 A. fumigatus strain CEA10 but present in strain Af293 (40)), while the other 9 have not been 268 biochemically connected to any metabolite. 269
270
Our analyses also showed that all the genes required for the production of the mycotoxin 271 gliotoxin (a mycotoxin) are located in a gene cluster in A. fischeri (Fig. S5 ), and are in fact very 272 similar to their A. fumigatus orthologs (41). A. fumigatus and A. fischeri gliotoxin cluster gene 273 orthologs share on average approximately 94% of their protein sequences, a level of similarity 274 comparable to that exhibited between all reciprocal best blast hit pairs in A. fumigatus and A. 275 fischeri (93%). However, the A. fischeri copy of GliZ (Afu6g09630), the cluster-specific 276 regulator of gliotoxin production in A. fumigatus, only shared 78% of its protein sequence with 277 its A. fischeri counterpart. It is thus possible that differences in how gliotoxin cluster genes are 278 regulated in the two species could be responsible for why A. fischeri is not known to produce this 279 mycotoxin (42). 280 281 Both the gliotoxin and acetylaszonalenin gene clusters are located immediately next to one 282 another ( Fig. S5 ) in A. fischeri. In A. fumigatus, the gliotoxin gene cluster is immediately next to 283 what appears to be a version of the acetylaszonalenin cluster that is lacking portions of the 284 14 nonribosomal peptide synthase and acetyltransferase and the entire indole prenyltransferase 285 required for acetylaszonalenin production. The close proximity of these two gene clusters is 286 noteworthy, as it is another example of a rapidly evolving "super cluster" in A. fumigatus and A. 287 fumigatus-related strains (43) . These super clusters have been hypothesized to be "evolutionary 288 laboratories" that may give rise to new compounds and pathways (40). 289 290 Isolation and characterization of three new compounds from A. fischeri 291
The relatively low level of conservation we observed at the genomic loci likely 292 responsible for secondary metabolism in A. fumigatus and A. fischeri led us to characterize the 293 secondary metabolites A. fischeri produced using solid state fermentation with commercially 294 available rice, followed by extraction and purification via HPLC ( Fig. S6 ) (44-48). The fractions 295 from the solid-state culture yielded three known compounds, sartorypyrone A (1), aszonalenin 296 (4), and acetylaszonalenin (5) ( Fig. 5A ). To better explore the chemical diversity of A. fischeri, 297 the one strain-many compounds (OSMAC) approach was used to alter the secondary metabolites 298 being biosynthesized (49-52). A. fischeri was subsequently grown on multigrain cheerios and 299 yielded the three secondary metabolites from rice (1, 4, and 5), and four additional secondary 300 metabolites fumitremorgin A (6), fumitremorgin B (7), verruculogen (8), and the C-11 epimer of 301 verruculogen TR2 (9). These results suggest that culture media influences the biosynthesis of 302 secondary metabolites in A. fischeri as observed in many other fungi (50, 53). 303
304
To further explore the effect of culture conditions on secondary metabolism in A. fischeri, 305 secondary metabolite production was evaluated in a suite of growth conditions, including both 306 synthetic and rich media (Figs. 5B and S7 and Table S4 ) and the chemical profile was assessed 307 15 by Liquid Chromatography-Mass Spectrometry (LC-MS). The analysis showed that oatmeal agar 308 (OMA) produced chromatographic peaks that were not seen in any other growth media. This 309 finding prompted a scale-up to characterize the peaks of interest. This process yielded the seven 310 previously isolated compounds (1 and 4-9) and three newly biosynthesized secondary 311 metabolites (2, 3, and 10). Two of the secondary metabolites were new compounds 312 (sartorypyrone E (2) and 14-epi-aszonapyrone A (3)) and one was a new natural product (13-O-313 prenyl-fumitremorgin B (10)) ( Fig. 5B ). The structures were determined using a set of 314 spectroscopic (1 and 2D NMR) and spectrometric techniques (HRMS). Our data for 315 sartorypyrone A (1) (54), aszonalenin (4) (55, 56), acetylaszonalenin (5) Since four secondary metabolites (5-8) from A. fischeri had also been reported from A. 324 fumigatus, we hypothesized that the mechanisms A. fischeri employs to regulate its secondary 325 metabolism would also be similar to those used by A. fumigatus. To test this hypothesis, we 326 constructed deletion mutants of laeA in A. fischeri (Fig. S8 ). LaeA is a master regulator of 327 secondary metabolism in A. fumigatus and a variety of other fungi (65-67). Both the wild type 328 and Δ laeA strains were subjected to LC-MS analysis at a concentration of 2.0 mg/mL, and with a 329 gradient starting at 15% CH 3 CN and linearly increasing to 100% CH 3 CN over 8 minutes. The 330 16 chromatographic profile of Δ laeA showed mass data that corresponded to sartorypyrone A (1), 331 sartorypyrone E (2), 14-epi-aszonapyrone A (3), aszonalenin (4), acetylaszonalenin (5), 332 fumitremorgin A (6), verruculogen (8), and the C-11 epimer of verruculogen TR2 (9). However, 333 the relative abundance of compounds present was very low compared to the wild type ( Fig. 5C ). Our data suggested that A. fischeri strain NRRL 181 is able to grow in a mammalian host 348 but is much less fit than A. fumigatus strain CEA10. Consequently, phenotypic analyses of a 349 single strain of each species revealed significant differences in their ability to adapt to known 350 pathogenesis-related stress environments including low oxygen, oxidative stress-inducing agents, 351 and cell wall perturbing molecules. Moreover, basic differences in the growth of the two 352 organisms at multiple temperatures and under multiple diverse nutrient conditions revealed 353 17 fundamental metabolic differences between these two strains and species. These differences in 354 disease-relevant traits led us to look for the genomic attributes that were responsible for them. 355
The only A. fumigatus gene required for virulence that was missing from A. fischeri was a gene 356 encoding a nonribosomal peptide synthase required for fumigaclavine C biosynthesis (Table S1) . 357 Fumigaclavine C biosynthesis is required for A. fumigatus pathogenicity (68) and is a potent 358 anti-inflammatory (69). We were surprised to see an anti-inflammatory gene missing in A. 359 fischeri considering our histology data suggests that A. fumigatus recruits more inflammatory 360 cells to sites of fungal lesions. However, additional quantitative analyses of the host immune 361 response to these species is needed, and multiple factors contribute to the development of 362 inflammation and host damage during infection including, but not limited to, fungal secondary 363 metabolites. In addition, O'Hanlon et al. reported that the loss of pesL in A. fumigatus resulted in 364 increased production of fumitremorgins; compounds similar or identical to those were isolated 365 during our chemical study ( Fig 5AB) . 366 367 Further investigations into the conservation and divergence of secondary metabolic gene 368 clusters in A. fischeri and A. fumigatus revealed that secondary metabolic genes are much less 369 conserved than genes in the rest of the genome. This finding is consistent with our previous 370 results showing that secondary metabolism is a dynamic process that evolves quickly between 371 closely related species or even between strains of the same species (40, 70). Ten gene clusters 372 were A. fischeri-specific (i.e. they did not possess orthologs in the list of secondary metabolic 373 cluster genes present in A. fumigatus) (Fig 3. ), implying that they were either gained by A. 374 fischeri or lost by A. fumigatus. A further examination of the secondary metabolic cluster gene 375 repertoire in other section Fumigati species is needed to discern the evolutionary pattern of these 376 "A. fischeri-specific" gene clusters. 377 378 Cluster 18 was the only gene cluster found to be A. fumigatus-specific and contains an 379 uncharacterized squalene-hopene cyclase, a class of enzymes that contribute to the production of 380 molecules important for membrane fluidity in Bacteria (71). The presence of the small molecule 381 produced by Cluster 18 in the membrane of A. fumigatus could contribute to its ability to evade 382 the host immune system and/or be less susceptible to the infection-relevant stresses we tested 383 relative to A. fischeri. 384
385
We report here for the first time two compounds isolated from A. fischeri (sartorypyrone 386 E (2) and 14-epi-aszonapyrone (3)) in addition to the first natural production of 13-O-prenyl-387 fumitremorgin B (10). 13-O-prenyl-fumitremorgin B was previously produced in vitro using 388 purified fumitremorgin B, dimethylallyl pyrophosphate, and the prenyltransferase FtmPT3 389 (NFIA_093400) (62), but this is the first report of its natural production and isolation from A. 390 fischeri. Interestingly, FtmPT3 is not located in the previously described fumitremorgin cluster 391 (72) but is located relatively near it in another predicted antiSMASH cluster (Cluster 9). 392
393
LaeA is a master regulator of secondary metabolism in a diverse set of organisms (65, 67, 394 73), and we have shown here that it functions similarly in A. fischeri (Fig. 5C ). Every metabolite 395 we isolated from the wild type strain decreased in abundance in the ΔlaeA strain, and 396 fumitremorgin B (7) and 13-O-prenyl-fumitremorgin B (10) were not produced by the mutant at 397 all. Our data matches reports of laeA regulating fumitremorgin production in A. fumigatus (15, 398 19 74) and suggests at least a partially conserved network of laeA regulation in A. fischeri. 399
Furthermore, our finding that laeA regulates the acetylaszonalenin cluster shows that this 400 important gene controls the production of global secondary metabolism in A. fischeri and not 401 only orthologs of the targets of laeA from A. fumigatus. 402 403 Together, our data suggests that A. fischeri is less virulent in murine models of infection 404 than its closest sequenced relative, A. fumigatus, despite significant conservation between their 405 genomes. Based on our results, we hypothesize that the decrease in virulence of A. fischeri 406 relative to A. fumigatus is due at least in part to differences in the ability of the two organisms to 407 respond to pathogenesis-relevant stresses and their different secondary metabolite profiles. The 408 differences in the pathobiology traits between these two species warrant further investigation, 409 especially as the appreciation for the health burden caused by species in the subgenus Fumigati 410
increases. An important future direction is to expand these studies to include larger numbers of 411 strains and species from section Fumigati in order to fully appreciate the biological and genetic 412 diversity in this important subgenus. Leveraging this diversity will allow us to better understand 413 the nature and evolution of human fungal pathogenesis. 414 415
Materials and Methods 416

Strains and growth media 417
A. fischeri strain NRRL 181 was acquired from the ARS Culture Collection (NRRL). All 418 strains were maintained on glucose minimal media (GMM) from glycerol stocks stored at -80°C. 419
All strains were grown in the presence of white light at 37°C. Conidia were collected in 0.01% To identify putative orthologous genes (hence forth referred to as orthologs) between A. 508 fischeri and A. fumigatus, a reciprocal best BLAST hit (RBBH) approach was used. We blasted 509 the proteome of A. fischeri to A. fumigatus and vice versa using an e-value cutoff of 10 -3 and then 510 filtered for RBBHs according to bitscore (75). A pair of genes from each species was considered 511 24 orthologous if their best blast hit was to each other. Species-specific and orthologous protein sets 512 were visualized using version 3.0.0 of eulerAPE (76). 513 514 Enriched Gene Ontology annotations were identified in gene lists using the tools 515 available at FungiDB (77) (accessed on July 25, 2018), and lists were collapsed using the 516 "Small" setting in REVIGO (78) . prtA gene, conferring resistance to pyrithiamine, which was placed within the cassette as a 546 dominant marker, was amplified from the pPRT1 plasmid by using the primers prtA NF010750 547 5´rv (5´-GTAATCAATTGCCCGTCTGTCAGATCCAGGTCGAGGAGGTCCAATCGG-3´) 548 and prtA NF010750 3´fw (5´-549 CGGCTCATCGTCACCCCATGATAGCCGAGATCAATCTTGCATCC-3´). The deletion 550 cassette was generated by transforming each fragment along with the plasmid pRS426 cut with 551
BamHI/EcoRI into the S. cerevisiae strain SC94721, using the lithium acetate method (85). The 552 DNA from the transformants was extracted by the method described by Goldman et al. (86) . The 553 cassette was PCR-amplified from these plasmids utilizing TaKaRa Ex Taq™ DNA Polymerase 554 (Clontech Takara Bio) and used for A. fisheri transformation according to the protocol described 555 by Malavazi and Goldman (84) . Southern blot and PCR analyses were used to demonstrate that 556 the cassette had integrated homologously at the targeted A. fischeri locus. Genomic DNA from 557 26 A. fischeri was extracted by grinding frozen mycelia in liquid nitrogen and then gDNA was 558 extracted as previously described (84). Standard techniques for manipulation of DNA were 559 carried out as described (87). For Southern blot analysis, restricted chromosomal DNA fragments 560 were separated on 1% agarose gel and blotted onto Hybond N + nylon membranes (GE 561 Healthcare). Probes were labeled using [α-32 P]dCTP using the Random Primers DNA Labeling 562 System (Life Technologies). Labeled membranes were exposed to X-ray films, which were 563 scanned for image processing. Southern blot and PCR schemes are shown in Fig. S8 . Aspergillus fischeri was initially grown on rice for two weeks, and then extracted using methods 908 outlined in Fig. S6 . The rice culture yielded compounds 1, 4, and 5. Middle, A. fischeri was 909 grown on multigrain Cheerios for two weeks, which yielded compounds 1 and 4-9. Bottom, A. 910 fischeri on Quaker oatmeal for two weeks. All compounds that were previously isolated in rice 911 and multigrain cheerios cultures in addition to three new compounds (2, 3, and 10) the chemistry profiles varied based on growth conditions. PDA + ab was used as the chemical 974 control to observe the differences in the secondary metabolites, due to it being the media that A. 975 fischeri is stored. There were overall no chemical differences observed between the different 976 variations of PDA media. Each peak (which indicates different chemical entities) was observed 977 in the three PDA variations, albeit at fluctuating intensities. SDA, PYG, and YESD produced the 978 majority of the peaks observed in PDA, but it also lacked some observed peaks, indicating that 979 these growth conditions were not chemically favored. CYA produced the majority of the peaks, 980 as well as an additional peak that was observed at a much lower intensity in PDA. However, this 981 peak was similarly observed in OMA. OMA produced similar peaks to those observed in PDA, 982 but with higher intensity. Due to this, OMA was selected to further study. 
